Sort   by:  
 Page size 

Background

Circulating tumor DNA (ctDNA) is a novel biomarker to predict recurrence in colorectal cancer (CRC). However, clinical validation data in underrepresented patient populations like Southeast Asians are lacking.

Materials and methods

In our prospective clinical trial, 92 pati...
Sort   by:  
 Page size